Financials
- Market Capitalization 41.91 M
- Employee 17
- Founded 2018
- CEO N/A
- Website www.instilbio.com
- Headquarter New York, United States
- FIGI BBG00ZGYN521
- Industry Biotechnologies
Chiffre d'affaires total
Résultat net
Bénéfice par action de base (BPA de base)
Dette totale
Flux de trésorerie disponible
Trésorerie et équivalents de trésorerie
ratio cours/bénéfice
-1.03
ratio cours/chiffre d'affaires
151.55
Related tickers
| # | Nom | Prix | 24h % | 7 jours % | 1M % | 1 an % | Cap Boursière | 7 Derniers Jours | |
|---|---|---|---|---|---|---|---|---|---|
| 4199 | CELU Celularity Inc. - Class A Common Stock | 1.42 USD | -3.40% | -7.19% | +6.77% | -36.61% | 46.08 M USD | ||
| 4205 | ANVS Annovis Bio, Inc. Common Stock | 1.06 USD | -7.02% | -10.17% | -5.36% | -35.37% | 45.16 M USD | ||
| 4230 | GRCE Grace Therapeutics, Inc. - Common Stock | 1.99 USD | -1.49% | -3.40% | -13.10% | -50.00% | 41.86 M USD | ||
| 4240 | OABIW OmniAb, Inc. - Warrant | 0.2835 USD | -26.84% | -26.84% | -27.31% | +68.75% | 41.22 M USD |